Download
11897_2024_Article_661.pdf 1,92MB
WeightNameValue
1000 Titel
  • (Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis
1000 Autor/in
  1. Wernhart, Simon |
  2. Michel, Lars |
  3. Carpinteiro, Alexander |
  4. Luedike, Peter |
  5. Rassaf, Tienush |
1000 Verlag
  • Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-18
1000 Erschienen in
1000 Quellenangabe
  • 21(3):224-237
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11897-024-00661-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090960/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose of Review</jats:title> <jats:p>Cardiac amyloidosis (CA) constitutes an important etiology of heart failure with preserved ejection fraction (HFpEF) or heart failure with mildly reduced ejection fraction (HFmrEF). Since patients with CA show early exhaustion, we aimed to investigate whether non-exertional variables of cardiopulmonary exercise testing (CPET) provide additional information in comparison to traditional peak oxygen consumption (VO<jats:sub>2peak</jats:sub>).</jats:p> </jats:sec><jats:sec> <jats:title>Recent Findings</jats:title> <jats:p>We retrospectively investigated CPET variables of patients with HFpEF and HFmrEF with (<jats:italic>n</jats:italic> = 21) and without (<jats:italic>n</jats:italic> = 21, HF) CA at comparable age and ejection fraction. Exertional and non-exertional CPET variables as well as laboratory and echocardiographic markers were analyzed. The primary outcome was the difference in CPET variables between groups. The secondary outcome was rehospitalization in patients with CA during a follow-up of 24 months. Correlations between CPET, NTproBNP, and echocardiographic variables were calculated to detect patterns of discrimination between the groups. HF patients with CA were inferior to controls in most exertional and non-exertional CPET variables. Patients with CA were hospitalized more often (<jats:italic>p</jats:italic> = 0.002), and rehospitalization was associated with VE/VCO<jats:sub>2</jats:sub> (<jats:italic>p</jats:italic> = 0.019), peak oxygen pulse (<jats:italic>p</jats:italic> = 0.042), the oxygen equivalent at the first ventilatory threshold (<jats:italic>p</jats:italic> = 0.003), circulatory (<jats:italic>p</jats:italic> = 0.024), and ventilatory power (<jats:italic>p</jats:italic> &lt; .001), but not VO<jats:sub>2peak</jats:sub> (<jats:italic>p</jats:italic> = 0.127). Higher performance was correlated with lower E/e’ and NTproBNP as well as higher resting heart rate and stroke volume in CA.</jats:p> </jats:sec><jats:sec> <jats:title>Summary</jats:title> <jats:p>Patients with CA displayed worse non-exertional CPET performance compared to non-CA HF patients, which was associated with rehospitalization. Differences between correlations of resting echocardiography and CPET variables between groups emphasize different properties of exercise physiology despite comparable ejection fraction.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Topical Collection on Cardio-Oncology
lokal Aged [MeSH]
lokal Exercise Test/methods [MeSH]
lokal Chronic heart failure
lokal Cardiomyopathies/diagnosis [MeSH]
lokal Stroke Volume/physiology [MeSH]
lokal Cardiomyopathies/physiopathology [MeSH]
lokal Male [MeSH]
lokal Oxygen Consumption/physiology [MeSH]
lokal Echocardiography/methods [MeSH]
lokal Exercise Tolerance/physiology [MeSH]
lokal Non-exertional variables
lokal Phenotyping
lokal Female [MeSH]
lokal Amyloidosis/physiopathology [MeSH]
lokal CPET
lokal Heart Failure/physiopathology [MeSH]
lokal Humans [MeSH]
lokal Cardiac amyloidosis
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Heart Failure/complications [MeSH]
lokal Amyloidosis/complications [MeSH]
lokal Amyloidosis/diagnosis [MeSH]
lokal Review
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-6732-0939|https://frl.publisso.de/adhoc/uri/TWljaGVsLCBMYXJz|https://frl.publisso.de/adhoc/uri/Q2FycGludGVpcm8sIEFsZXhhbmRlcg==|https://frl.publisso.de/adhoc/uri/THVlZGlrZSwgUGV0ZXI=|https://frl.publisso.de/adhoc/uri/UmFzc2FmLCBUaWVudXNo
1000 Hinweis
  • DeepGreen-ID: a4c8e3af25ff4e8b8fe199616f60ab23 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Essen |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Essen |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6523396.rdf
1000 Erstellt am 2025-07-06T21:18:24.018+0200
1000 Erstellt von 322
1000 beschreibt frl:6523396
1000 Zuletzt bearbeitet 2025-07-29T15:57:58.501+0200
1000 Objekt bearb. Tue Jul 29 15:57:58 CEST 2025
1000 Vgl. frl:6523396
1000 Oai Id
  1. oai:frl.publisso.de:frl:6523396 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source